Sierra Oncology Announces Abstracts Accepted for American Society of Clinical Oncology Annual Meeting

SAN MATEO, Calif.: —New momelotinib analysis examining the association between transfusion independence and overall survival to be presented— SAN MATEO, Calif., May 19, 2021 May 19, 2021 - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today...

Click to view original post